Enliven Therapeutics, Inc.
Industry: Life Sciences ・ $ELVN on Nasdaq
Insider Sale
+$14,514
-0.05%
Shares
Shares Volume: 527 Shares
Average Share Price: $27.54
INSIDER
Lyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER (Officer)
reported on Oct 3 2024
traded on Oct 1 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 1,077,409 |
| PURCHASES/SALES 1Y | 0 / 16 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $216,898.22 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 4 |
| PURCHASES/SALES 1Y | 0 / 86 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $922,637.1 |
| COMPANY PREVIOUS TRADES |